| 영문 | gene | 한글 | 유전자 |
|---|---|---|---|
| 설명 | 유전자는 길게 띠를 형성한 DNA분자의 일부분으로 한 가지 물질을 만드는데 필요한 모든 정보를 갖춘 기능적인 단위이다. 예를 들어 인슐린이라는 물질의 유전자라고 하면 사람의 세포내에 있는 긴 DNA 분자 중에서 인슐린이라는 물질을 만드는데 필요한 모든 정보를 가지고 있는 한 부분을 가리키는 말이다. 고전적인 생물학에서는 유전자가 표현형을 결정하거나 지정하는 염색체의 일부분이라고 정의되었지만, 오늘날에는 유전자에 대해서 분자적 정의가 제안되고 있으며 그 정의는 하나의 유전자는 하나의 효소를 결정 또는 암호화하는 유전물질의 일부분이라는 개념으로 이것이 이른바 1개의 유전자 1개 효소가설(one gene-one enzyme hypothesis)이다. 즉 1개의 유전자는 1개의 효소를 제작하는데 필요한 유전정보를 가진다는 것이다. 현재 이 가설이 받아들여지고 있다. |
||
| 영문 | gene therapy | 한글 | 유전자요법 |
|---|---|---|---|
| 설명 | 유전병을 치료할 목적으로, 정상적으로 기능하는 단일유전자 혹은 복수유전자를 어떤 기원에서 얻어내어 생세포에 도입하는 것. 유전물질은 유전자삽입 조작에 의해 수용세포에로 도입된다. 즉, 유전자를 끼워 넣은 새로운 세포를 사용하는 치료로서 1980년 미국의 학자가 지중해빈혈환자에게 강행하여 비판을 받았지만, 미국 국립보건연구소는 1990년 9월 아데노신 데아미나아제(adenosine deaminase, ADA) 결핍증 환자의 림프구에 ADA 유전자를 끼워 넣는 치료를 시작한 이래 현재는 암을 포함한 많은 질병들을 치료하는 목적으로 쓰인다. |
||
| ACTS | acute cervical traumatic sprain or syndrome; advanced communication technology satellite; American C... |
|---|---|
| AMHT | automated multiphasic health testing |
| ASTM | American Society for Testing and Materials |
| DARTS | Drug and Alcohol Rehabilitation Testing System |
| DAUs | drug abuse testing and urines |
| ASTM | American Society for Testing and Materials |
|---|---|
| ET | Exercise Testing |
| EST | Exercise stress testing |
| ETT | Exercise treadmill testing |
| FOBT | Faecal occult blood testing |
| gene testing | Testing a sample of blood (or another fluid or tissue) for evidence of a gene. The evidence can be biochemical, chromosomal, or genetic. The aim is to learn whether a gene for a disease is present or absent. (12 Dec 1998) |
|---|
| allergy testing | <investigation> A common method of screening a patient for potential allergies. May be given as a patch or a skin test (injection). (27 Sep 1997) |
|---|---|
| animal testing | <pharmacology> Before researchers test pharmaceuticals in human clinical trials, they test them in animals to determine toxicity, dosing, and efficacy. What they learn in animal models helps them determine if it is safe and worthwhile to proceed to human trials, and how best to design those trials. (14 Nov 1997) |
| animal testing alternatives | Procedures, such as tissue culture, mathematical models, etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories. (12 Dec 1998) |
| anonymous testing | Testing in which no name is used there is total anonymity to identify the person tested. For example, the State of Florida requires that each county have a site for anonymous HIV testing. (12 Dec 1998) |
| bench testing | Testing of a device against specifications in a simulated (nonliving) environment. (05 Mar 2000) |
| mandatory testing | Testing or screening required by federal, state, or local law or other agencies for the diagnosis of specified conditions. It is usually limited to specific populations such as categories of health care providers, members of the military, and prisoners or to specific situations such as premarital examinations or donor screening. (12 Dec 1998) |
| reality testing | The individual's objective evaluation of the external world and the ability to differentiate adequately between it and the internal world; considered to be a primary ego function. (12 Dec 1998) |
| genetic testing | Identifying foetuses or infants afflicted with hereditary diseases or conditions, and carriers of recessive disorders by means of DNA analysis. See: DNA markers, familial screening, prenatal screening. Synonym: genetic testing. (05 Mar 2000) |
| materials testing | The testing of materials and devices, especially those used for implants, prostheses, sutures, adhesives, etc., for hardness, strength, durability, safety, and efficacy. (12 Dec 1998) |
| histocompatibility testing | Identification of the major histocompatibility antigens of transplant donors and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical abo blood group, and in addition should be matched as closely as possible for histocompatibility antigens in order to minimise the likelihood of allograft rejection. (12 Dec 1998) |
| susceptibility testing | The determination of the ability of an antibiotic to kill or inhibit the growth of bacteria. (05 Mar 2000) |
| testing | 1. The act of testing or proving; trial; proof. 2. <chemistry> The operation of refining gold or silver in a test, or cupel; cupellation. <engineering> Testing machine, a machine used in the determination of the strength of materials, as iron, stone, etc, and their behavior under strains of various kinds, as elongation, bending, crushing, etc. Source: Websters Dictionary (01 Mar 1998) |
| testing, anonymous | Testing in which no name or other means is used to identify the person tested. There is total anonymity. For example, the state of florida requires that each county have a site for anonymous HIV testing. (12 Dec 1998) |
| allelic gene | See: allele, dominance of traits. (05 Mar 2000) |
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| gene testing |
Examining a sample of blood or other body fluid or tissue for biochemical, chromosomal, or genetic markers that indicate the presence or absence of genetic disease
출처: aspin.asu.edu/geneinfo/glos-g.htm
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|